Xi-Trump summit ends with few deals, but a managed decline of U.S.-China relations may be the point28 September 2026
Airbnb CEO Brian Chesky spends 3 hours a day recruiting—he tells managers who don’t like it to leave28 September 2026
Travis Kalanick is back: How Uber’s ousted founder went from pariah to Silicon Valley hero28 September 2026
Smoking Cessation Aid Cytisinicline Could Soon Get FDA ApprovalBy Press Room5 July 2025 More than two-thirds of American smokers say they want to quit. However, besides nicotine replacement therapies, there are at present…
Promising Schizophrenia Drug, Cobenfy, Will Likely Face Access ChallengesBy Press Room5 November 2024 Cobenfy (xanomeline/trospium chloride; formerly KarXT) was approved for schizophrenia in adults by the Food and Drug Administration in late September.…
Winrevair Gains Approval For Pulmonary Arterial Hypertension, But High Price Could Limit UptakeBy Press Room2 April 2024 The Food and Drug Administration approved Winrevair last week. The drug is indicated for a rare and deadly cardiovascular disorder…
House Of Representatives Passes Bill To Ban Use Of QALYs In Federally Funded Healthcare ProgramsBy Press Room9 February 2024 The U.S. House of Representatives passed H.R. 485, the Protecting Health Care for All Patients Act, this week. The bill…